{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:19:43Z","timestamp":1787959183901,"version":"build-2784847793"},"reference-count":35,"publisher":"Georg Thieme Verlag KG","funder":[{"name":"CSL Behring","award":["ZVT No. ZVS-2019092402 (to BZ), EK222-20"],"award-info":[{"award-number":["ZVT No. ZVS-2019092402 (to BZ), EK222-20"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Platelet-type von Willebrand disease (PT-VWD) is a rare thrombocytopathy caused by gain-of-function variants in GP1BA, leading to increased binding of von Willebrand factor (VWF). Because its phenotype closely resembles VWD type 2B (VWD 2B), misdiagnosis is common, and distinction requires Ristocetin-induced platelet agglutination (RIPA) mixing studies and molecular genetic analysis. Although individual case reports, case series, and earlier summaries exist, an updated and comprehensive synthesis of all published cases has been lacking. We report a 4-year-old boy presenting with easy bruising, prolonged epistaxis, reduced VWF parameters (VWF collagen-binding activity 0.07 U\/mL, VWF-antigen 0.33 U\/mL), absence of high-molecular-weight multimers, and enhanced RIPA. Genetic testing identified the pathogenic GP1BA variant p.Met255Val, causing PT-VWD. RIPA mixing studies confirmed the diagnosis. In the course of the disease, the patient developed recurrent mucosal bleeding and a hypersensitivity reaction to tranexamic acid. Therefore, desmopressin was used, and he showed partial clinical benefit from desmopressin without developing thrombocytopenia. To contextualize this case, we performed a literature review (PubMed, May 2025) and identified 67 documented patients with PT-VWD. Over 40% were initially misclassified as VWD 2B. p.Gly249Val and p.Met255Val were the most frequent variants. Baseline thrombocytopenia occurred in approximately one-third of cases, and pregnancy-associated thrombocytopenia was common. According to the literature, platelet transfusions were most effective (in case of major hemorrhage or surgical setting); VWF concentrates or desmopressin showed variable efficacy and occasional transient thrombocytopenia. These data demonstrate the diagnostic challenges of PT-VWD and emphasize the importance of clinical case collection to improve therapeutical management.<\/jats:p>","DOI":"10.1055\/a-2940-6179","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:59:01Z","timestamp":1787957941000},"source":"Crossref","is-referenced-by-count":0,"title":["Platelet Type Von Willebrand Disease \u2013 Diagnostic and Therapeutic Challenges"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7081-8604","authenticated-orcid":false,"given":"Rebekka","family":"Wiedenhoefer","sequence":"additional","affiliation":[{"name":"University of Freiburg Faculty of Medicine, Baden-W\u00fcrttemberg, Germany","place":["Freiburg"],"department":["Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-2904","authenticated-orcid":false,"given":"Doris","family":"Boeckelmann","sequence":"additional","affiliation":[{"name":"University of Freiburg Faculty of Medicine, Baden-W\u00fcrttemberg, Germany","place":["Freiburg"],"department":["Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2750-7229","authenticated-orcid":false,"given":"Hannah","family":"Glonnegger","sequence":"additional","affiliation":[{"name":"University of Freiburg Faculty of Medicine, Baden-W\u00fcrttemberg, Germany","place":["Freiburg"],"department":["Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[{"name":"University Clinic Bonn, Germany","place":["Bonn"],"department":["Institute of Experimental Haematology and Transfusion Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Zieger","sequence":"additional","affiliation":[{"name":"University of Freiburg Faculty of Medicine, Baden-W\u00fcrttemberg, Germany","place":["Freiburg"],"department":["Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"102682","DOI":"10.1016\/j.rpth.2025.102682","article-title":"Global prevalence of platelet-type von Willebrand disease","volume":"9","author":"O Seidizadeh","year":"2025","journal-title":"Res Pract Thromb Haemost"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V60.3.790.790","article-title":"Platelet-type von Willebrand\u2019s disease: characterization of a new bleeding disorder","volume":"60","author":"J L Miller","year":"1982","journal-title":"Blood"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1182\/blood.V81.7.1787.1787","article-title":"Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor","volume":"81","author":"S D Russell","year":"1993","journal-title":"Blood"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1046\/j.1538-7836.2003.00369.x","article-title":"Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease","volume":"1","author":"Y Matsubara","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1182\/blood-2002-09-2942","article-title":"Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease","volume":"105","author":"M Othman","year":"2005","journal-title":"Blood"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1160\/TH12-04-0189","article-title":"A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease","volume":"108","author":"S Enayat","year":"2012","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0033-1364183","article-title":"Identification of p.W246L as a novel mutation in the GP1BA gene responsible for platelet-type von Willebrand disease","volume":"40","author":"A I Woods","year":"2014","journal-title":"Semin Thromb Hemost"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jth.13204","article-title":"Platelet type von Willebrand disease and registry report: communication from the SSC of the ISTH","volume":"14","author":"M Othman","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref9","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1182\/bloodadvances.2021005463","article-title":"A p.Arg127Gln variant in GPIb\u03b1 LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD","volume":"6","author":"L Bury","year":"2022","journal-title":"Blood Adv"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1160\/TH16-06-0438","article-title":"A novel platelet-type von Willebrand disease mutation (GP1BA p.Met255Ile) associated with type 2B \u201cMalm\u00f6\/New York\u201d von Willebrand disease","volume":"116","author":"C Lavenu-Bombled","year":"2016","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/bjh.19025","article-title":"A new case of platelet-type von Willebrand disease supports the recent findings of gain-of-function GP1BA variants outside the C-terminal disulphide loop enhances affinity for von Willebrand factor","volume":"203","author":"C Monteiro","year":"2023","journal-title":"Br J Haematol"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/09537104.2016.1237625","article-title":"PT-VWD posing diagnostic and therapeutic challenges \u2013 small case series","volume":"28","author":"A S\u00e1nchez-Luceros","year":"2017","journal-title":"Platelets"},{"issue":"08","key":"ref13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/jth.14827","article-title":"Guidance on the diagnosis and management of platelet-type von Willebrand disease: a communication from the platelet physiology subcommittee of the ISTH","volume":"18","author":"M Othman","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00134-011-2370-6","article-title":"Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS)","volume":"38","author":"C Heilmann","year":"2012","journal-title":"Intensive Care Med"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"M Elbatarny","year":"2014","journal-title":"Haemophilia"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1365-2141.2006.06078.x","article-title":"Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance","volume":"133","author":"M S Enayat","year":"2006","journal-title":"Br J Haematol"},{"issue":"02","key":"ref17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2141.2006.06411.x","article-title":"2B or not 2B? Differential identification of type 2B, versus pseudo-,von Willebrand disease","volume":"136","author":"I N Whalley","year":"2007","journal-title":"Br J Haematol"},{"issue":"7905","key":"ref18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"J Morales","year":"2022","journal-title":"Nature"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood.V74.6.2028.2028","article-title":"A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma","volume":"74","author":"A Casonato","year":"1989","journal-title":"Blood"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ajh.2830180404","article-title":"Replacement therapy in platelet-type von Willebrand disease","volume":"18","author":"H Takahashi","year":"1985","journal-title":"Am J Hematol"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood.V85.3.727.bloodjournal853727","article-title":"Substitution of Val for met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease","volume":"85","author":"H Takahashi","year":"1995","journal-title":"Blood"},{"issue":"05","key":"ref22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00001721-199707000-00009","article-title":"De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease","volume":"8","author":"S Kunishima","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis","volume":"139","author":"E J Favaloro","year":"2007","journal-title":"Br J Haematol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH06-10-0579","article-title":"A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene","volume":"97","author":"P Nurden","year":"2007","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.2009.015990","article-title":"Diagnosis of platelet-type von Willebrand disease by flow cytometry","volume":"95","author":"S Giannini","year":"2010","journal-title":"Haematologica"},{"issue":"03","key":"ref26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1160\/TH10-08-0523","article-title":"Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study","volume":"105","author":"A Hamilton","year":"2011","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref27","first-page":"386","article-title":"Pregnancy in platelet-type VWD: a case series","volume":"106","author":"D O'Connor","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2393-13-16","article-title":"Pseudo (platelet-type) von Willebrand disease in pregnancy: a case report","volume":"13","author":"N Grover","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-0035-1548915","article-title":"Delayed diagnosis of platelet-type von Willebrand disease in a 72-year-old lady","volume":"227","author":"M Maurer","year":"2015","journal-title":"Klin Padiatr"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/bloodadvances.2025017674","article-title":"Developing an artificial intelligence-generated peptide targeting platelet-type von Willebrand disease","volume":"10","author":"T DD Kazmirchuk","year":"2026","journal-title":"Blood Adv"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1111\/jth.14597","article-title":"Platelet-type von Willebrand disease: local disorder of the platelet GPIb\u03b1 \u03b2-switch drives high-affinity binding to von Willebrand factor","volume":"17","author":"A Tischer","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3324\/haematol.2018.200378","article-title":"Mechanisms of thrombocytopenia in platelet-type von Willebrand disease","volume":"104","author":"L Bury","year":"2019","journal-title":"Haematologica"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1016\/j.jtha.2025.04.021","article-title":"International opinion survey on nomenclature for platelet-type von Willebrand disease: communication from the SSC of the ISTH","volume":"23","author":"M Othman","year":"2025","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/ajpath.2008.070417","article-title":"Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease","volume":"172","author":"L J Suva","year":"2008","journal-title":"Am J Pathol"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng.3466","article-title":"Exploring genomic alteration in pediatric cancer using ProteinPaint","volume":"48","author":"X Zhou","year":"2016","journal-title":"Nat Genet"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2940-6179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:59:05Z","timestamp":1787957945000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2940-6179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1055\/a-2940-6179","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}